These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16023905)

  • 21. Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a clinical review and update.
    Rubin DT; Cruz-Correa MR; Gasche C; Jass JR; Lichtenstein GR; Montgomery EA; Riddell RH; Rutter MD; Ullman TA; Velayos FS; Itzkowitz S;
    Inflamm Bowel Dis; 2008 Feb; 14(2):265-74. PubMed ID: 17932965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ursodeoxycholic acid and chemoprevention of colorectal cancer.
    Serfaty L; Bissonnette M; Poupon R
    Gastroenterol Clin Biol; 2010 Oct; 34(10):516-22. PubMed ID: 20609543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
    Triantafillidis JK; Nasioulas G; Kosmidis PA
    Anticancer Res; 2009 Jul; 29(7):2727-37. PubMed ID: 19596953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of diet, life style, and other environmental/chemopreventive factors on colorectal cancer development, and assessment of the risks.
    Ahmed FE
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2004; 22(2):91-147. PubMed ID: 16291519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemoprevention of colorectal cancer: why all the confusion?
    Bresalier RS
    Curr Opin Gastroenterol; 2008 Jan; 24(1):48-50. PubMed ID: 18043232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review article: the chemoprevention of colorectal carcinoma.
    Gasche C
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():31-5. PubMed ID: 15352891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel disease.
    Stange EF
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():64-7. PubMed ID: 16961748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunopharmacology of 5-aminosalicylic acid and of glucocorticoids in the therapy of inflammatory bowel disease.
    Nikolaus S; Fölscn U; Schreiber S
    Hepatogastroenterology; 2000; 47(31):71-82. PubMed ID: 10690587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of arachidonic acid regulatory enzymes in colorectal disease.
    Abir F; Alva S; Kaminski DL; Longo WE
    Dis Colon Rectum; 2005 Jul; 48(7):1471-83. PubMed ID: 15868226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-steroidal anti-inflammatory drugs and colorectal cancer prevention.
    Sangha S; Yao M; Wolfe MM
    Postgrad Med J; 2005 Apr; 81(954):223-7. PubMed ID: 15811884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Aminosalicylic acid and chemoprevention: does it work?
    Lopez A; Peyrin-Biroulet L
    Dig Dis; 2013; 31(2):248-53. PubMed ID: 24030235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chemoprevention of colorectal cancer in inflammatory bowel disease].
    Han SH; Lee J
    Korean J Gastroenterol; 2014 Jan; 63(1):3-10. PubMed ID: 24463282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [5-aminosalicylic acid and cancer prophylaxis?].
    Thomsen OO
    Ugeskr Laeger; 2006 May; 168(21):2047. PubMed ID: 16768920
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemoprevention of colorectal cancer with nonsteroidal anti-inflammatory drugs.
    Hilmi I; Goh KL
    Chin J Dig Dis; 2006; 7(1):1-6. PubMed ID: 16412030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclooxygenase-2 inhibitors in colorectal cancer prevention: point.
    Arber N
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):1852-7. PubMed ID: 18708371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chemoprevention of colorectal cancer].
    Stelmaszuk T; Jałocha L; Wojtuń S; Gil J
    Pol Merkur Lekarski; 2009 May; 26(155):565-8. PubMed ID: 19606728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Folate and colorectal cancer: an evidence-based critical review.
    Kim YI
    Mol Nutr Food Res; 2007 Mar; 51(3):267-92. PubMed ID: 17295418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemoprevention in gastrointestinal adenocarcinoma: for few but not for all?
    Bazuro GE; Torino F; Gasparini G; Capurso L
    Minerva Gastroenterol Dietol; 2008 Dec; 54(4):429-44. PubMed ID: 19047983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folate and its preventive potential in colorectal carcinogenesis. How strong is the biological and epidemiological evidence?
    Bollheimer LC; Buettner R; Kullmann A; Kullmann F
    Crit Rev Oncol Hematol; 2005 Jul; 55(1):13-36. PubMed ID: 15927841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease.
    Terdiman JP; Steinbuch M; Blumentals WA; Ullman TA; Rubin DT
    Inflamm Bowel Dis; 2007 Apr; 13(4):367-71. PubMed ID: 17206695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.